Pharmagen ApS: Financial statements 2021
CVR: 36687193
Source: annual report 2021, Danish Business Authority
01/10/2020 – 30/09/2021
Pharmagen ApS (CVR 36687193) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 337,172 and a net result of DKK 383,322 compared with DKK 75,955 the year before. That is a decrease of 9.7% compared with the year before. Equity in the 2021 report amounted to DKK -65,096.
- Gross Profit
- DKK 337,172
- Profit/Loss
- DKK 383,322
- Equity
- DKK -65,096
- Total Assets
- DKK 1,226,752
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 337 t. | 383 t. | -65 t. | - |
| 2020 | - | 373 t. | 76 t. | -448 t. | - |
| 2019 | - | 382 t. | -907 t. | -524 t. | - |
| 2018 | - | 345 t. | -237 t. | 383 t. | - |
| 2017 | - | 357 t. | 270 t. | 619 t. | - |
Official annual report
Find more companies like Pharmagen ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout Pharmagen ApS
Pharmagen ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Mads Juul Hedegaard. The company is owned by Hans-Ole Hedegaard. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -15,933 and a net result of DKK 36,023 compared with DKK -19,304 the year before. Equity in the 2025 report amounted to DKK -275,141.